Literature DB >> 1316087

Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.

B Z Katz1, U Saini.   

Abstract

The authors recently demonstrated that 40% of Epstein-Barr virus (EBV) associated lymphoproliferative lesions contained lytic as well as latent EBV DNA. To examine more fully the replicative state of EBV in these disorders, the authors studied protein extracts of EBV-associated lymphoid lesions from 13 patients, most of whom were immunosuppressed, for expression of the diffuse early antigen (EA-D) of EBV, by immunoblotting techniques. The reagent used was a mouse monoclonal antibody. Seven of thirteen samples (54%) contained EA-D. These data indicate that in EBV-associated lymphoproliferative lesions, lytic viral replication occurs frequently, manifested by the presence of EBV diffuse early antigen as well as by the presence of lytic EBV DNA replication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316087      PMCID: PMC1886516     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1990. A 16-year-old boy with a seizure disorder and past meningitis, current hepatic failure, and free intraperitoneal air.

Authors: 
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

2.  Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil.

Authors:  B Brichácek; I Hirsch; O Síbl; E Vilikusová; V Vonka
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

Review 3.  Epstein-Barr virus and the X-linked lymphoproliferative syndrome.

Authors:  J L Sullivan
Journal:  Adv Pediatr       Date:  1983

4.  Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.

Authors:  G R Pearson; B Vroman; B Chase; T Sculley; M Hummel; E Kieff
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

5.  Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis.

Authors:  G W Bornkamm; H Stein; K Lennert; F Rüggeberg; H Bartels; H zur Hausen
Journal:  Int J Cancer       Date:  1976-02-15       Impact factor: 7.396

6.  Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins.

Authors:  L S Young; S Finerty; L Brooks; F Scullion; A B Rickinson; A J Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

Authors:  K Hennessy; S Fennewald; M Hummel; T Cole; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Central-nervous-system lymphoma related to Epstein-Barr virus.

Authors:  F H Hochberg; G Miller; R T Schooley; M S Hirsch; P Feorino; W Henle
Journal:  N Engl J Med       Date:  1983-09-29       Impact factor: 91.245

9.  Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.

Authors:  R Weigel; G Miller
Journal:  Virology       Date:  1983-03       Impact factor: 3.616

10.  Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.

Authors:  M Rowe; L S Young; J Crocker; H Stokes; S Henderson; A B Rickinson
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  8 in total

1.  Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.

Authors:  Barbara C Gärtner; Hansjörg Schäfer; Katja Marggraff; Günter Eisele; Marco Schäfer; Dagmar Dilloo; Klaus Roemer; Hans-Jürgen Laws; Martina Sester; Urban Sester; Hermann Einsele; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

3.  Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease.

Authors:  P S Randhawa; A Zeevi; C Alvares; S Gollin; R Agostini; E Yunis; S Saidman; L Contis; A J Demetris; M A Nalesnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-06       Impact factor: 2.416

Review 4.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes.

Authors:  R Rochford; D E Mosier
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Epstein-Barr virus infection in HIV-positive patients.

Authors:  A Telenti; D E Uehlinger; F Marchesi; D Germann; R Malinverni; L Matter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

Review 7.  The antiviral prophylaxis of post-transplant lymphoproliferative disorder.

Authors:  C L Davis
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Lymphoproliferative disorder in a lung transplant recipient.

Authors:  Hassan A Haji; Douglas S Corwin; Jennifer Y So; Robert M Reed
Journal:  BMJ Case Rep       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.